BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25881212)

  • 1. Full thickness macular hole case after intravitreal aflibercept treatment.
    Oshima Y; Apte RS; Nakao S; Yoshida S; Ishibashi T
    BMC Ophthalmol; 2015 Mar; 15():30. PubMed ID: 25881212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tear in the retinal pigment epithelium by intravitreal injection of aflibercept].
    Bertelmann T; Sekundo W; Wenner Y
    Ophthalmologe; 2014 Aug; 111(8):775-7. PubMed ID: 24062151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.
    Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H
    Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MACULAR ATROPHY AND MACULAR MORPHOLOGY IN AFLIBERCEPT-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Kuroda Y; Yamashiro K; Ooto S; Tamura H; Oishi A; Nakanishi H; Miyata M; Hata M; Takahashi A; Wakazono T; Yoshimura N; Tsujikawa A
    Retina; 2018 Sep; 38(9):1743-1750. PubMed ID: 28691937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration.
    Sato T; Ooto S; Suzuki M; Spaide RF
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):87-90. PubMed ID: 25559517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REOPENING OF MACULAR HOLE AFTER INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Chan EW; Sun V; Chen JC
    Retin Cases Brief Rep; 2020; 14(3):255-259. PubMed ID: 29252912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous rip of the retinal pigment epithelium with a macular hole in neovascular age-related macular degeneration.
    Emerson GG; Ghazi NG
    Am J Ophthalmol; 2005 Aug; 140(2):316-8. PubMed ID: 16086957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
    Sridhar J; Hsu J; Shahlaee A; Garg SJ; Spirn MJ; Fineman MS; Vander J
    JAMA Ophthalmol; 2016 Apr; 134(4):437-43. PubMed ID: 26914218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-thickness macular hole after intravitreal injection of ranibizumab in a patient with retinal pigment epithelium detachment and tear.
    Grigoropoulos V; Emfietzoglou J; Nikolaidis P; Theodossiadis G; Theodossiadis P
    Eur J Ophthalmol; 2010; 20(2):469-72. PubMed ID: 20037902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD.
    Batioglu F; Demirel S; Özmert E; Abdullayev A; Bilici S
    BMC Ophthalmol; 2015 Apr; 15():40. PubMed ID: 25885684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration.
    Mazaraki K; Fassnacht-Riederle H; Blum R; Becker M; Michels S
    Br J Ophthalmol; 2015 Oct; 99(10):1341-4. PubMed ID: 25877895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous combined full-thickness retinal and pigment epithelium macular hole in age-related macular degeneration.
    Panthier C; Querques G; Zerbib J; Souied EH
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):208-10. PubMed ID: 23413892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal pigment epithelial tear after intravitreous triamcinolone acetonide injection for fibrovascular pigment epithelial detachment.
    Wu PC; Chen YJ; Kuo HK
    Chang Gung Med J; 2011; 34(3):320-5. PubMed ID: 21733363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment.
    Clemens CR; Bastian N; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.
    Abdelfattah NS; Zhang H; Boyer DS; Rosenfeld PJ; Feuer WJ; Gregori G; Sadda SR
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1839-46. PubMed ID: 27082298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability.
    Hata M; Oishi A; Tsujikawa A; Yamashiro K; Miyake M; Ooto S; Tamura H; Nakanishi H; Takahashi A; Yoshikawa M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7874-80. PubMed ID: 25395483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.